Praxis Precision Medicines dismisses EY as auditor, engages KPMG

Praxis Precision Medicines, Inc.

Audit Committee dismissed Ernst & Young LLP as independent auditor effective June 29, 2026.
No disagreements or reportable events occurred during FY2024, FY2025, or through June 29, 2026.
EY's reports on financial statements for FY2024 and FY2025 were unqualified, with no adverse opinion.
KPMG LLP was engaged as new independent registered public accounting firm effective June 29, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.